Literature DB >> 19675169

Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis.

Taylor R Dagenais1, Bailey E Freeman, Karen P Demick, Donna M Paulnock, John M Mansfield.   

Abstract

Th1 cell responses to the variant surface glycoprotein (VSG) of African trypanosomes play a critical role in controlling infection through the production of IFN-gamma, but the role of APCs in the induction and regulation of T cell-mediated protection is poorly understood. In this study, we have investigated the Ag presentation capabilities of dendritic cells (DCs) and macrophages during early trypanosome infection in relatively resistant responder and susceptible nonresponder mouse strains. Splenic DCs appeared to be the primary cell responsible for activating naive VSG-specific Th cell responses in resistant responder animals through the coordinated up-regulation of costimulatory molecules, secretion of IL-12, and presentation of VSG peptides to T cells in vivo. Splenic DC depletion and the down-regulation of costimulatory markers on splenic macrophages were observed in susceptible animals and may be associated with the inability of these animals to elicit a significant VSG-specific T cell response. In contrast to splenic APCs, peritoneal macrophages secreted NO, failed to activate naive Th cells in vitro, and presented relatively low levels of VSG peptides to T cells in vivo. Thus, VSG-specific Th1 cell responses may be determined by tissue- and cell-specific differences in Ag presentation. Additionally, all APCs from resistant and susceptible strains displayed a reduced ability to process and present newly encountered exogenous Ag, including new VSG molecules, during high parasitemia. Thus, initial uptake of VSG (or other trypanosome factors) may interfere with Ag presentation and have dramatic consequences for subsequent T cell responses to other proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675169      PMCID: PMC2730433          DOI: 10.4049/jimmunol.0802005

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei.

Authors:  G A Cross
Journal:  Parasitology       Date:  1975-12       Impact factor: 3.234

2.  Resistance to the African trypanosomes is IFN-gamma dependent.

Authors:  C J Hertz; H Filutowicz; J M Mansfield
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

Review 3.  Regulation of host cell function by glycosylphosphatidylinositols of the parasitic protozoa.

Authors:  L Schofield; S D Tachado
Journal:  Immunol Cell Biol       Date:  1996-12       Impact factor: 5.126

4.  Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections.

Authors:  S Magez; M Radwanska; A Beschin; K Sekikawa; P De Baetselier
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Albumin nitrosylated by activated macrophages possesses antiparasitic effects neutralized by anti-NO-acetylated-cysteine antibodies.

Authors:  S Mnaimneh; M Geffard; B Veyret; P Vincendeau
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

6.  The soluble variant surface glycoprotein of African trypanosomes is recognized by a macrophage scavenger receptor and induces I kappa B alpha degradation independently of TRAF6-mediated TLR signaling.

Authors:  Brian J Leppert; John M Mansfield; Donna M Paulnock
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering.

Authors:  Alexander D Edwards; Shivanthi P Manickasingham; Roman Spörri; Sandra S Diebold; Oliver Schulz; Alan Sher; Tsuneyasu Kaisho; Shizuo Akira; Caetano Reis e Sousa
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

8.  Genetics of resistance to Trypanosoma congolense in inbred mice: efficiency of apparent clearance of parasites correlates with long-term survival.

Authors:  O Ogunremi; H Tabel
Journal:  J Parasitol       Date:  1995-12       Impact factor: 1.276

9.  Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles.

Authors:  Hai Qi; Timothy L Denning; Lynn Soong
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Two variant surface glycoproteins of Trypanosoma brucei of different sequence classes have similar 6 A resolution X-ray structures.

Authors:  P Metcalf; M Blum; D Freymann; M Turner; D C Wiley
Journal:  Nature       Date:  1987 Jan 1-7       Impact factor: 49.962

View more
  13 in total

1.  The Trypanosoma brucei gambiense secretome impairs lipopolysaccharide-induced maturation, cytokine production, and allostimulatory capacity of dendritic cells.

Authors:  Edwin Garzón; Philippe Holzmuller; Rachel Bras-Gonçalves; Philippe Vincendeau; Gérard Cuny; Jean Loup Lemesre; Anne Geiger
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

2.  Distinct Contributions of CD4+ and CD8+ T Cells to Pathogenesis of Trypanosoma brucei Infection in the Context of Gamma Interferon and Interleukin-10.

Authors:  Gongguan Liu; Donglei Sun; Hui Wu; Mingshun Zhang; Haixia Huan; Jinjun Xu; Xiquan Zhang; Hong Zhou; Meiqing Shi
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

3.  Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling.

Authors:  Tom Bosschaerts; Martin Guilliams; Benoît Stijlemans; Yannick Morias; Daniel Engel; Frank Tacke; Michel Hérin; Patrick De Baetselier; Alain Beschin
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

4.  Intradermal infections of mice by low numbers of african trypanosomes are controlled by innate resistance but enhance susceptibility to reinfection.

Authors:  Guojian Wei; Harold Bull; Xia Zhou; Henry Tabel
Journal:  J Infect Dis       Date:  2010-12-14       Impact factor: 5.226

5.  Genetic control of resistance to Trypanosoma brucei brucei infection in mice.

Authors:  Matyáš Síma; Helena Havelková; Lei Quan; Milena Svobodová; Taťána Jarošíková; Jarmila Vojtíšková; Alphons P M Stassen; Peter Demant; Marie Lipoldová
Journal:  PLoS Negl Trop Dis       Date:  2011-06-07

6.  Oxidation by neutrophils-derived HOCl increases immunogenicity of proteins by converting them into ligands of several endocytic receptors involved in antigen uptake by dendritic cells and macrophages.

Authors:  Rafał Biedroń; Maciej K Konopiński; Janusz Marcinkiewicz; Szczepan Józefowski
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

Review 7.  Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids.

Authors:  Anne Geiger; Géraldine Bossard; Denis Sereno; Joana Pissarra; Jean-Loup Lemesre; Philippe Vincendeau; Philippe Holzmuller
Journal:  Front Immunol       Date:  2016-05-31       Impact factor: 7.561

Review 8.  Host Intracellular Signaling Events and Pro-inflammatory Cytokine Production in African Trypanosomiasis.

Authors:  Shiby M Kuriakose; Rani Singh; Jude E Uzonna
Journal:  Front Immunol       Date:  2016-05-19       Impact factor: 7.561

Review 9.  To the Skin and Beyond: The Immune Response to African Trypanosomes as They Enter and Exit the Vertebrate Host.

Authors:  Omar A Alfituri; Juan F Quintana; Annette MacLeod; Paul Garside; Robert A Benson; James M Brewer; Neil A Mabbott; Liam J Morrison; Paul Capewell
Journal:  Front Immunol       Date:  2020-06-12       Impact factor: 7.561

10.  IL-27 Signaling Is Crucial for Survival of Mice Infected with African Trypanosomes via Preventing Lethal Effects of CD4+ T Cells and IFN-γ.

Authors:  Gongguan Liu; Jinjun Xu; Hui Wu; Donglei Sun; Xiquan Zhang; Xiaoping Zhu; Stefan Magez; Meiqing Shi
Journal:  PLoS Pathog       Date:  2015-07-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.